In Other News

• Ultrasonic Fine-Needle Biopsy Tool Improves Salivary Gland Tumor Diagnosis

• Liquid Biopsy Biomarkers Distinguish Inflammatory Breast Cancer and Support Monitoring

• Biomarker Signals Chemotherapy Resistance in Relapsed Small Cell Lung Cancer

• Roche to Acquire PathAI for Up to $1.05 Billion to Strengthen AI Diagnostics Portfolio

• Blood Test Maps Tumor Microenvironment to Predict Immunotherapy Response

• FDA-Cleared Viscoelastic Testing System Supports Obstetric Bleeding Management

• FDA Clears AI Digital Pathology Tool for Breast Cancer Risk Stratification

• Inflammatory Gene Signature Links Metabolic Disease to Pancreatic Cancer Recurrence

• New AI Tool Reveals Hidden Genetic Signals in Routine H&E Slides

• Multiplex Respiratory Panel Integrates Automated Extraction to Streamline High-Volume Testing

• Inflammatory Gene Signature Links Metabolic Disease to Pancreatic Cancer Recurrence

• Multiplex Respiratory Panel Integrates Automated Extraction to Streamline High-Volume Testing

• Whole-Blood RNA Test Predicts Disease Trajectory and Treatment Response

• Blood-Based Epigenetic Test Predicts GLP-1 Response and Tracks Treatment Effects

• Tumor-on-a-Chip Platform Models Pancreatic Cancer Treatment Response

• Study Links Abnormal Gene Splicing to Treatment Response in Metastatic Kidney Cancer

• Ultrasensitive Test Detects Key Biomarker of Frontotemporal Dementia Subtype

• AI System Analyzes Routine Pathology Slides to Predict Cancer Outcomes

• FDA Clears Blood-Based Companion Diagnostic for Advanced Breast Cancer Therapy

• Tumor Genomic Testing Guides Immunotherapy Selection in Pituitary Tumors

• Rapid Tongue Swab Molecular Test Detects Pulmonary Tuberculosis at Point of Care

• New Platform Captures Extracellular Vesicles for Early Cancer Detection

• Research Reveals How Some Aplastic Anemia Patients Recover Bone Marrow Function